These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35314661)

  • 1. Validation of In Vivo Nodal Assessment of Solid Malignancies with USPIO-Enhanced MRI: A Workflow Protocol.
    Driessen DAJJ; de Gouw DJJM; Stijns RCH; Litjens G; Israël B; Philips BWJ; Hermans JJ; Dijkema T; Klarenbeek BR; van der Post RS; Nagtegaal ID; van Engen-van Grunsven ACH; Brosens LAA; Veltien A; Zámecnik P; Scheenen TWJ
    Methods Protoc; 2022 Mar; 5(2):. PubMed ID: 35314661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Accuracy Nodal Staging of Head and Neck Cancer With USPIO-Enhanced MRI: A New Reading Algorithm Based on Node-to-Node Matched Histopathology.
    Driessen DAJJ; Zámecnik P; Dijkema T; Pegge SAH; van Engen-van Grunsven ACH; Takes RP; Kaanders JHAM; Scheenen TWJ
    Invest Radiol; 2022 Dec; 57(12):810-818. PubMed ID: 35776432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USPIO-enhanced MRI of lymph nodes in rectal cancer: A node-to-node comparison with histopathology.
    Stijns RCH; Philips BWJ; Nagtegaal ID; Polat F; de Wilt JHW; Wauters CAP; Zamecnik P; Fütterer JJ; Scheenen TWJ
    Eur J Radiol; 2021 May; 138():109636. PubMed ID: 33721766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients.
    Thoeny HC; Triantafyllou M; Birkhaeuser FD; Froehlich JM; Tshering DW; Binser T; Fleischmann A; Vermathen P; Studer UE
    Eur Urol; 2009 Apr; 55(4):761-9. PubMed ID: 19144456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential of Iron Oxide Nanoparticle-Enhanced MRI at 7 T Compared With 3 T for Detecting Small Suspicious Lymph Nodes in Patients With Prostate Cancer.
    Tenbergen CJA; Fortuin AS; van Asten JJA; Veltien A; Philips BWJ; Hambrock T; Orzada S; Quick HH; Barentsz JO; Maas MC; Scheenen TWJ
    Invest Radiol; 2024 Jul; 59(7):519-525. PubMed ID: 38157433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferumoxtran-10-enhanced MRI for pre-operative metastatic lymph node detection in pancreatic, duodenal, or periampullary adenocarcinoma.
    Litjens G; Nakamoto A; Brosens LAA; Maas MC; Scheenen TWJ; Zámecnik P; van Geenen EJM; Prokop M; van Laarhoven KJHM; Hermans JJ
    Eur Radiol; 2024 Dec; 34(12):7973-7984. PubMed ID: 38907886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.
    Birkhäuser FD; Studer UE; Froehlich JM; Triantafyllou M; Bains LJ; Petralia G; Vermathen P; Fleischmann A; Thoeny HC
    Eur Urol; 2013 Dec; 64(6):953-60. PubMed ID: 23916692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes.
    Koh DM; George C; Temple L; Collins DJ; Toomey P; Raja A; Bett N; Farhat S; Husband JE; Brown G
    AJR Am J Roentgenol; 2010 Jun; 194(6):W505-13. PubMed ID: 20489069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
    Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
    Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study.
    Pultrum BB; van der Jagt EJ; van Westreenen HL; van Dullemen HM; Kappert P; Groen H; Sietsma J; Oudkerk M; Plukker JT; van Dam GM
    Cancer Imaging; 2009 Apr; 9(1):19-28. PubMed ID: 19414293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Magnetic Resonance Imaging in (Future) Cancer Staging: Note the Nodes.
    Scheenen TWJ; Zamecnik P
    Invest Radiol; 2021 Jan; 56(1):42-49. PubMed ID: 33156126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer.
    Rockall AG; Sohaib SA; Harisinghani MG; Babar SA; Singh N; Jeyarajah AR; Oram DH; Jacobs IJ; Shepherd JH; Reznek RH
    J Clin Oncol; 2005 Apr; 23(12):2813-21. PubMed ID: 15837995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria.
    Tokuhara T; Tanigawa N; Matsuki M; Nomura E; Mabuchi H; Lee SW; Tatsumi Y; Nishimura H; Yoshinaka R; Kurisu Y; Narabayashi I
    Gastric Cancer; 2008; 11(4):194-200. PubMed ID: 19132480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Harada T; Tanigawa N; Matsuki M; Nohara T; Narabayashi I
    Eur J Radiol; 2007 Sep; 63(3):401-7. PubMed ID: 17398053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
    Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
    Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison between Gd-DTPA-enhanced MRI and USPIO-enhanced MRI in diagnosing benign and metastatic cervical lymph nodes in rabbit models].
    Feng Y; Zhang GX; Wang H; Hu YS; Wang XF; Zheng LF
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):813-8. PubMed ID: 21223685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.
    Cooper KL; Meng Y; Harnan S; Ward SE; Fitzgerald P; Papaioannou D; Wyld L; Ingram C; Wilkinson ID; Lorenz E
    Health Technol Assess; 2011 Jan; 15(4):iii-iv, 1-134. PubMed ID: 21276372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymph node image with ultrasmall superparamagnetic iron oxide and comparison with pathological result].
    Xue HD; Lei J; Li Z; Wang DT; Zhou WX; Dai W; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):139-45. PubMed ID: 19507589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer.
    Triantafyllou M; Studer UE; Birkhäuser FD; Fleischmann A; Bains LJ; Petralia G; Christe A; Froehlich JM; Thoeny HC
    Eur J Cancer; 2013 Feb; 49(3):616-24. PubMed ID: 23084842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancers.
    Baghi M; Mack MG; Hambek M; Rieger J; Vogl T; Gstoettner W; Knecht R
    Anticancer Res; 2005; 25(5):3665-70. PubMed ID: 16101198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.